Türk Medline
ADR Yönetimi
ADR Yönetimi

AN INCIDENTALLY DIAGNOSED HEPATOCELLULAR CARCINOMA THAT EXHIBITED UNUSUAL METASTASIS

MERYEM DEMİR, TUBA TASLAMACIOĞLU DUMAN, ÜMMÜGÜL ÜYETÜRK, SELMA ERDOĞAN DÜZCÜ, BUKET BÜŞRA BAŞAR

Turkish Journal of Oncology - 2019;34(2):114-118

Department of Internal Medicine, Abant İzzet Baysal University Training and Research Hospital, Bolu-Turkey

 

Hepatocellular carcinoma (HCC) is the most common primary liver cancer. It can be diagnosed at a late stage due to the lack of early symptom onset and its non-pathognomonic symptoms. Metastatic regions often include the lung, lymph nodes, bones, and adrenal glands. Soft tissue and central nervous system (CNS) metastases are extremely rare. The incidence of CNS metastasis ranges from 0.6% to 1.7%. Curative treatment is liver transplantation or resection in early stages. In advanced stages, local therapies include transarterial chemoembolization and radioembolization. Systemic treatments, such as sorafenib, regorafenib, ramucirumab, and nivolumab, are applied in the metastatic stage. We aimed to present with literature the case of HCC that was diagnosed incidentally and had rare metastasis of soft tissue and CNS and long-term overall survival.